| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | 1 | — | — | — | 2 | — | — | — | — | — | — |
| Sell | — | — | 1 | — | — | 1 | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 38.45 | 52.49 | 56.52 | 70.52 |
| Receivables | 380.15 | 534.86 | 556.00 | 711.92 |
| Inventory | — | — | — | — |
| Other | 194.08 | 248.38 | 286.73 | 221.76 |
| 612.69 | 835.73 | 899.25 | 1,004.20 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 82.83 | 90.65 | 90.93 | 115.51 |
| ST’ Debt | — | 66.18 | 66.37 | 83.98 |
| Other | 257.12 | 315.67 | 305.07 | 239.58 |
| 511.92 | 705.80 | 735.59 | 683.85 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 848.58 | 682.21 | — | — |
—
|
| ’25 | 838.01 | 683.50 | 693.82 | 542.66 |
2,757.99
|
| ’24 | 494.30 | 420.01 | 438.88 | 460.28 |
1,813.47
|
| ’23 | 454.61 | 398.50 | 410.54 | 327.55 |
1,591.19
|
| ’22 | 391.72 | 361.95 | 363.26 | 295.04 |
1,411.98
|
| ’21 | 300.73 | 278.65 | 282.72 | 242.83 |
1,104.93
|
| ’20 | 277.46 | 236.94 | 238.39 | 211.11 |
963.90
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (25.51) | 147.74 | — | — |
—
|
| ’25 | (88.27) | 113.15 | 23.97 | 143.64 |
192.49
|
| ’24 | (63.72) | 88.16 | 43.73 | 55.52 |
123.69
|
| ’23 | (44.51) | 74.24 | 27.53 | 96.25 |
153.51
|
| ’22 | (50.89) | 79.40 | 31.55 | 66.07 |
126.13
|
| ’21 | (14.83) | 81.12 | 14.65 | 50.21 |
131.15
|
| ’20 | (18.65) | 74.17 | 26.27 | 65.05 |
146.85
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (28.51) | 139.00 | — | — |
—
|
| ’25 | (93.44) | 105.20 | 22.06 | 141.72 |
175.53
|
| ’24 | (68.84) | 86.31 | 41.05 | 52.26 |
110.78
|
| ’23 | (48.11) | 66.11 | 20.22 | 92.24 |
130.46
|
| ’22 | (51.72) | 76.59 | 29.16 | 63.46 |
117.49
|
| ’21 | (15.97) | 79.01 | 11.46 | 47.68 |
122.17
|
| ’20 | (21.29) | 71.51 | 22.09 | 62.96 |
135.27
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2.63 | 0.31 | — | — |
—
|
| ’25 | 1.91 | 0.66 | 0.48 | (1.28) |
1.83
|
| ’24 | 1.53 | 0.39 | 0.70 | (1.53) |
0.78
|
| ’23 | 1.44 | 0.53 | 0.67 | (0.26) |
2.39
|
| ’22 | 1.10 | 0.60 | 0.53 | (0.23) |
2.01
|
| ’21 | 0.92 | 0.16 | 0.41 | (0.19) |
1.32
|
| ’20 | 0.66 | 0.39 | 0.36 | 0.00 |
1.41
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35.46 | 45.22 | 60.59 | 47.89 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 51.67 | 63.12 | 86.36 | 90.13 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,500 | 6,700 | 10,000 | 9,500 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.22 | 0.24 | 0.18 | 0.29 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,411.98 | 1,591.19 | 1,813.47 | 2,757.99 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.82% | 14.03% | 10.06% | 12.89% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 141.48 | 166.30 | 57.81 | 160.84 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.02% | 10.45% | 3.19% | 5.83% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 105.35 | 120.97 | 41.04 | 115.44 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 32.90 | 36.74 | 49.32 | 103.74 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27.42 | 31.83 | 34.62 | 43.84 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 2.01 | 2.39 | 0.78 | 1.83 | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.45 | 3.07 | 2.36 | 3.06 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.17) | (0.46) | (0.25) | (0.27) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.28 | 2.61 | 2.12 | 2.79 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.85 | 15.84 | 33.99 | 28.01 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 51.50 | 49.99 | 52.38 | 62.91 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.32 | 26.00 | 75.07 | 28.50 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.70 | 1.94 | 2.36 | 1.15 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.37 | 3.91 | 2.41 | 1.80 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.89 | 2.14 | 3.11 | 1.66 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.71 | 26.08 | 50.85 | 26.05 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 126.13 | 153.51 | 123.69 | 192.49 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (8.64) | (23.05) | (12.91) | (16.96) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 117.49 | 130.46 | 110.78 | 175.53 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 56.02 | 100.76 | 129.92 | 163.66 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 299.65 | 310.83 | 1,399.93 | 1,455.92 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 266.47 | 272.37 | 1,347.45 | 1,399.40 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 713.45 | 791.62 | 1,779.98 | 1,762.07 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.01% | 6.17% | 1.26% | 2.60% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.74% | 9.71% | 1.47% | 4.63% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.86% | 16.07% | 3.19% | 6.52% | — | — | — |
ROE
|
CBIZ, Inc. (CBZ) has rocketed from a $800 million revenue player in 2016 to a near-$2 billion powerhouse by 2024, powered by a masterful acquisition spree that’s ballooned headcount 49% and diversified into high-demand areas like benefits consulting and wealth management. While 2024 brought integration hiccups—revenue surged 14% to $1.81 billion, but profits plunged 65% amid a 351% debt spike to $1.4 billion—the stage is set for explosive recovery, with analysts forecasting a staggering 54% revenue leap to $2.79 billion in 2025, EPS tripling to $1.93, and margins rebounding to 10%+ as synergies unlock.
Valuation screams opportunity: shares trade at a depressed 75x trailing EPS but just 14x forward 2025 estimates, with analyst targets implying 110-170% upside from current levels— a classic “buy the dip after the deal.” Free cash flow remains resilient at $2.12 per share, insiders show cautious confidence with net buys amid routine sells, and CBIZ’s track record of post-M&A rebounds points to multibagger potential over three years.
Macro tailwinds like regulatory complexity and healthcare shifts supercharge this services giant’s niches, positioning CBIZ for its next growth leg despite short-term debt risks. This undervalued gem could reward patient investors handsomely—dive into the full analysis for the charts, comps, and deal details that make it irresistible.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.